INmune Bio, Inc. (INMB)
NASDAQ·Healthcare·Biotechnology
$1.93
+4.32%
Mkt Cap $43.07M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$22.00
Range $22.00 – $22.00
Implied Upside
+1039.9%
Consensus $22.00 vs current $1.93
NASDAQ·Healthcare·Biotechnology
$1.93
+4.32%
Mkt Cap $43.07M
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$22.00
Range $22.00 – $22.00
+1039.9%
Consensus $22.00 vs current $1.93